Skip to content

Efavirenz

Efavirenz (Sustiva) is a non-nucleoside reverse transcriptase inhibitor commonly used in the management of specific viral infections. It functions by preventing the virus from multiplying, which assists in controlling the viral load within the body. The film-coated tablet formulation is listed below.

Sustiva

HIV Infection

200 · 600mg

Efavirenz 200mg and 600mg film-coated tablets, used in the management of HIV infection. An NNRTI that binds reverse transcriptase directly.

From$3.87/ tabletView

Key points

  • Used alongside other antiretroviral medicines to suppress HIV and help preserve immune system function over the long term.
  • Blocks reverse transcriptase, an enzyme central to how the virus reproduces, which halts formation of new viral particles.
  • Skin rashes, unusually vivid dreams, dizziness or shifts in mood have all been reported, mostly appearing soon after starting treatment.

What is Efavirenz?

Efavirenz is a pharmaceutical agent that acts as a key component within broader frameworks for HIV Management. By targeting specific viral enzymes, it effectively reduces the amount of the virus present. Different manufacturing sources offer this medication, though the core active compound remains the same across these options.

What Efavirenz is used for

This medication is primarily indicated for the treatment of HIV Infection. It is used in combination with other antiretroviral agents to suppress the virus and maintain immune function. Efavirenz contributes to long-term health outcomes by creating an environment where the virus struggles to replicate, which is essential for managing chronic viral conditions.

How does Efavirenz work?

Efavirenz works by binding directly to the reverse transcriptase enzyme, which the virus needs to copy its genetic material. By blocking this enzyme, the medication prevents the virus from producing new copies of itself. This process limits the spread of the virus to new cells, maintaining control over the infection.

Efavirenz brands and forms

Sustiva is the primary originator brand for this compound, though other generic versions may appear due to changing availability. Efavirenz is consistently manufactured as a film-coated tablet for oral administration. The choice between specific brands is often based on local availability and clinical preference.

Safety overview for Efavirenz

What to check before using this medicine

Review your medical history with a doctor, particularly regarding liver conditions, mental health concerns or previous reactions to antiretroviral therapies. Ensuring your baseline health markers are monitored is standard practice before beginning this regimen.

Possible reactions and tolerability

Common responses can include skin rashes or changes in sleep patterns, such as vivid dreams. Some individuals may experience dizziness or mood changes during the initial weeks of treatment. If symptoms persist or become distressing, consult a healthcare provider for a review of your plan.

Interactions and health factors

Efavirenz may interact with other medications, including those for cholesterol or certain botanical preparations. Always maintain an accurate record of all supplements and medications you consume. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.

Further reading